SG11201907950VA - Complexes for treating sensitivity - Google Patents

Complexes for treating sensitivity

Info

Publication number
SG11201907950VA
SG11201907950VA SG11201907950VA SG11201907950VA SG11201907950VA SG 11201907950V A SG11201907950V A SG 11201907950VA SG 11201907950V A SG11201907950V A SG 11201907950VA SG 11201907950V A SG11201907950V A SG 11201907950VA SG 11201907950V A SG11201907950V A SG 11201907950VA
Authority
SG
Singapore
Prior art keywords
melbourne
international
university
complexes
stannous
Prior art date
Application number
SG11201907950VA
Other languages
English (en)
Inventor
Eric Charles Reynolds
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900892A external-priority patent/AU2017900892A0/en
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of SG11201907950VA publication Critical patent/SG11201907950VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201907950VA 2017-03-14 2018-03-14 Complexes for treating sensitivity SG11201907950VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2017900892A AU2017900892A0 (en) 2017-03-14 Complexes for treating sensitivity
PCT/AU2018/050230 WO2018165707A1 (en) 2017-03-14 2018-03-14 Complexes for treating sensitivity

Publications (1)

Publication Number Publication Date
SG11201907950VA true SG11201907950VA (en) 2019-09-27

Family

ID=63521649

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907950VA SG11201907950VA (en) 2017-03-14 2018-03-14 Complexes for treating sensitivity

Country Status (15)

Country Link
US (2) US12303548B2 (enExample)
EP (1) EP3595630A4 (enExample)
JP (1) JP7138352B2 (enExample)
KR (1) KR102555722B1 (enExample)
CN (1) CN110475539A (enExample)
AU (1) AU2018233576B2 (enExample)
BR (1) BR112019018871A2 (enExample)
CA (1) CA3055086A1 (enExample)
EA (1) EA201991935A1 (enExample)
MX (1) MX2019010833A (enExample)
MY (1) MY201505A (enExample)
NZ (1) NZ757004A (enExample)
PH (1) PH12019550156A1 (enExample)
SG (1) SG11201907950VA (enExample)
WO (1) WO2018165707A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2755277T3 (es) 2006-02-09 2020-04-22 Univ Melbourne Composición de fluoruro y métodos para mineralización dental
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
US10912722B2 (en) 2013-12-24 2021-02-09 The University Of Melbourne Stabilized stannous compositions
SG11201907950VA (en) 2017-03-14 2019-09-27 Univ Melbourne Complexes for treating sensitivity
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864471A (en) 1968-12-20 1975-02-04 Colgate Palmolive Co Stable dentifrices containing a monofluorophosphate, an insoluble metaphosphate, and calcium carbonate
US3966901A (en) 1970-12-29 1976-06-29 Colgate-Palmolive Company Dentifrice preparation
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4157386A (en) 1978-05-18 1979-06-05 Rochelle Paul J Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
US4588763A (en) 1978-06-01 1986-05-13 Braennstroem Martin Ethyl acetate as solvent in cavity liners
NZ199891A (en) 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4357318A (en) 1981-07-31 1982-11-02 Richardson-Vicks Inc. Dentifrices with improved soluble fluoride availability
US4522805A (en) 1983-06-08 1985-06-11 Norman Gordon Tooth and gum dentifrice
US4672032A (en) 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
CA1315480C (en) 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US6056930A (en) 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5227154A (en) 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR100238551B1 (ko) 1992-06-29 2000-02-01 도우글라스 웨이르 민감성 치아 치료
US5447732A (en) * 1992-11-25 1995-09-05 Ajinomoto Co., Inc. High-absorption mineral-containing composition and foods
CH684773A5 (fr) 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JP3471431B2 (ja) 1994-07-18 2003-12-02 株式会社ジーシー 歯科用グラスアイオノマーセメント組成物
JP3340265B2 (ja) 1994-11-21 2002-11-05 一枝 山岸 歯の漂白剤
KR0140248B1 (ko) 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
PT748591E (pt) 1995-06-16 2002-04-29 Nestle Sa Caseinas micelares fluoradas
US6036944A (en) 1995-08-08 2000-03-14 Enamelon, Inc. Processes for the remineralization and mineralization of teeth
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4040705B2 (ja) 1996-01-24 2008-01-30 株式会社サンギ 口腔組成物
AUPN898296A0 (en) 1996-03-28 1996-04-26 Nulite Systems International Pty Ltd Elastomeric state glass ionomer cement
US5741773A (en) 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
JP2975337B2 (ja) 1997-02-20 1999-11-10 雪印乳業株式会社 カルシウム複合体
AUPO566297A0 (en) 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
JPH11228327A (ja) 1998-02-18 1999-08-24 Gc Corp 歯科用ペースト系グラスアイオノマーセメント組成物
JP3742523B2 (ja) 1998-02-27 2006-02-08 雪印乳業株式会社 高分子型カルシウム・ホスホペプチド複合体
US6120754A (en) 1998-03-11 2000-09-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6846500B1 (en) 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
AU2633900A (en) 1999-03-25 2000-10-16 Warner-Lambert Company Oral care chewing gums and confections
FR2791573B1 (fr) 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
US6149894A (en) 1999-05-14 2000-11-21 Colgate Palmolive Company Method for the manufacture of toothpaste
US6521215B2 (en) 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
US6685920B2 (en) 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
JP2001144695A (ja) 1999-11-17 2001-05-25 Matsushita Electric Ind Co Ltd 音声処理装置及び音声処理方法
GB9929919D0 (en) 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
US7727539B2 (en) 2001-03-14 2010-06-01 Drexel University Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
MXPA04006541A (es) 2002-01-03 2004-10-04 Procter & Gamble Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluoruro.
CA2469431C (en) 2002-01-03 2009-05-26 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
NZ522071A (en) 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
EP1603525B1 (en) 2002-12-27 2009-04-01 Kao Corporation Oral preparation system
JP3853785B2 (ja) 2002-12-27 2006-12-06 花王株式会社 口腔用組成物
JP4340069B2 (ja) 2003-01-10 2009-10-07 雪印乳業株式会社 カルシウム複合体の製造法
US20050089481A1 (en) 2003-10-23 2005-04-28 Gc Corporation Composition for caries prevention
JP2005145952A (ja) 2003-10-23 2005-06-09 Gc Corp う蝕予防用組成物
US20050118115A1 (en) 2003-10-24 2005-06-02 Fontenot Mark G. Accelerated tooth whitening method, composition and kit
US20060183081A1 (en) 2004-09-27 2006-08-17 Al Bevilacqua Tooth bleaching system and method
NZ555335A (en) 2004-11-25 2010-10-29 Univ Melbourne Phosphopeptide stabilised amorphous calcium phosphate complexes produced under acidic conditions
CA2611077C (en) 2005-06-07 2014-07-15 The University Of Melbourne Dental mineralization
PL1901702T3 (pl) 2005-06-24 2015-07-31 Univ Melbourne Kompleksy jonowe
EP1928265A2 (en) 2005-08-22 2008-06-11 Conagra Foods Packaged Foods Company, Inc. Cryogenic peeling process
JP5684454B2 (ja) 2005-11-25 2015-03-11 “ダブリューディーエス” カンパニー 口腔ケア用の治療及び予防組成物
US20070254260A1 (en) 2005-12-02 2007-11-01 Alden Wayne S Iv Oral care compositions, methods, devices and systems
ES2755277T3 (es) 2006-02-09 2020-04-22 Univ Melbourne Composición de fluoruro y métodos para mineralización dental
WO2008089066A1 (en) 2007-01-12 2008-07-24 Mcneil-Ppc, Inc. Mineralization toothpaste
CN107080702A (zh) * 2008-02-08 2017-08-22 高露洁-棕榄公司 口腔护理产品及其使用和制备方法
RU2543656C2 (ru) 2008-02-08 2015-03-10 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения и производства
GB0807224D0 (en) 2008-04-21 2008-05-28 Univ Dundee Remineralisation of calcified tissue
US9849310B2 (en) 2008-06-24 2017-12-26 Dental Alliance Holdings, Llc Dental appliance, oral care product and method of preventing dental disease
US9226895B2 (en) 2008-07-30 2016-01-05 Ultradent Products, Inc. Methods and kits for cleaning and remineralizing teeth
JP2010047494A (ja) 2008-08-20 2010-03-04 Gc Corp 歯牙塗布用組成物
JP5437692B2 (ja) 2009-04-30 2014-03-12 インターコンチネンタル グレート ブランズ エルエルシー チューインガム組成物、チューインガム製品、及びこれらの製造方法
MX2011011486A (es) 2009-05-18 2011-11-18 Colgate Palmolive Co Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
JP4693191B2 (ja) 2009-08-06 2011-06-01 日本歯科薬品株式会社 口腔用剤
JP2011073983A (ja) 2009-09-29 2011-04-14 Gc Corp 歯牙塗布用組成物
JP2011162470A (ja) * 2010-02-09 2011-08-25 Gc Corp 歯牙用被覆材
MX2012009313A (es) 2010-02-12 2012-11-06 Theocorp Holding Co Llc Metodos y composiciones para mejorar la resistencia mecanica de los dientes.
US9539445B2 (en) 2010-11-22 2017-01-10 Taipei Medical University Type of anion-containing calcium phosphate compound for dental remineralization
EP3424516A1 (en) 2011-01-24 2019-01-09 Basf Se Oral health improving compositions
CN104011574A (zh) 2011-12-27 2014-08-27 住友电气工业株式会社 光缆
JP2013163656A (ja) 2012-02-10 2013-08-22 Gc Corp 歯磨剤
GB201202341D0 (en) 2012-02-10 2012-03-28 Periproducts Ltd Multicomponent oral care compostion
WO2014050144A1 (ja) 2012-09-28 2014-04-03 江崎グリコ株式会社 象牙細管封鎖剤
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
US10912722B2 (en) * 2013-12-24 2021-02-09 The University Of Melbourne Stabilized stannous compositions
CN104001157B (zh) * 2014-05-27 2015-12-02 高益槐 一种防治骨质疏松症的复方制剂及其制备方法
KR20170100580A (ko) * 2014-12-24 2017-09-04 더 유니버시티 오브 멜버른 광화 플루오라이드 조성물
SG11201907950VA (en) 2017-03-14 2019-09-27 Univ Melbourne Complexes for treating sensitivity
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis
KR20210139320A (ko) 2019-03-13 2021-11-22 더 유니버시티 오브 멜버른 저광화된 병변의 은폐

Also Published As

Publication number Publication date
EA201991935A1 (ru) 2020-02-14
EP3595630A4 (en) 2021-01-13
KR102555722B1 (ko) 2023-07-13
US12303548B2 (en) 2025-05-20
PH12019550156A1 (en) 2020-03-16
JP7138352B2 (ja) 2022-09-16
KR20190126134A (ko) 2019-11-08
EP3595630A1 (en) 2020-01-22
BR112019018871A2 (pt) 2020-04-14
CN110475539A (zh) 2019-11-19
NZ757004A (en) 2023-05-26
US20250152666A1 (en) 2025-05-15
JP2020514351A (ja) 2020-05-21
MX2019010833A (es) 2019-10-30
MY201505A (en) 2024-02-27
AU2018233576B2 (en) 2021-06-24
CA3055086A1 (en) 2018-09-20
AU2018233576A1 (en) 2019-09-26
WO2018165707A1 (en) 2018-09-20
US20200197486A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
SG11201803920TA (en) Compounds and compositions useful for treating disorders related to ntrk
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201900480YA (en) Anti-tim-3 antibodies
SG11201900163PA (en) Macrocycle kinase inhibitors
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201811564QA (en) Methods of treating ovarian cancer
SG11201806624XA (en) Deposition of molybdenum thin films using a molybdenum carbonyl precursor
SG11201909011PA (en) Niraparib compositions
SG11201807660QA (en) Cyclic di-nucleotide compounds and methods of use
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201907950VA (en) Complexes for treating sensitivity
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201906386XA (en) Combination therapy involving diaryl macrocyclic compounds
SG11201909807TA (en) Methods of manufacturing of niraparib
SG11201804770QA (en) Method and arrangement for recovery of salt
SG11201907693VA (en) Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201900238UA (en) Compounds and methods for modulation of smn2
SG11201811671XA (en) Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
SG11201907927SA (en) Binding molecules that specifically bind to tau
SG11201809875VA (en) Compositions and methods for treating spinal muscular atrophy
SG11201805001UA (en) Method of treating influenza a
SG11202000124PA (en) Promoting hair growth and treatment of hair loss or excessive hair shedding
SG11201907951QA (en) Treatment for gingivitis